The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 1st 2025
In clinical trials, the dihydroergotamine (DHE) nasal powder had favorable safety profiles and rapid pain relief in patients with migraine with or without aura.
Teva and Immuneering Announce Teva's Purchase of 51% Equity Share of Genomic-Analysis Company
August 3rd 2015Teva Pharmaceutical Industries Ltd. and Immuneering Corporation announced that the companies have entered into an agreement in which Teva will purchase a 51% equity share of the company.
Read More